scholarly journals The significant and profound impacts of Gordon Life Science Institute

2020 ◽  
Vol 1 (3) ◽  
pp. 01-11
Author(s):  
Kuo-Chen Chou
Keyword(s):  
Research And Development ◽  
San Diego ◽  
Life Science ◽  
Science Institute ◽  
The World ◽  
Global Research

The “Gordon Life Science” or “GLS” Institute is the first Internet Institute in the world. Established by Prof. Dr. Kuo-Chen Chou in 2003, right after he was retired from “Pfizer Global Research and Development” in San Diego, California.

scholarly journals The Cradle of Gordon Life Science Institute and Its Development and Driving Force

2019 ◽  
pp. 1-28
Keyword(s):  
Driving Force ◽  
Life Science ◽  
Internet Research ◽  
Scientific Creativity ◽  
Non Profit ◽  
Science Institute ◽  
The World ◽  
Time And Energy ◽  
Funding Application ◽  
Research Institute

Gordon Life Science Institute is the first Internet Research Institute ever established in the world. It is a non-profit institute. Those scientists who are really dedicated themselves to science and loving science more than anything else can become its member. In the friendly door-opened Institute, they can maximize their time and energy to engage in their scientific creativity. They have also believed that science would be more truthful and wonderful if scientists do not have to spend a lot of time on funding application, and that great scientific findings and creations in history were often made by those who were least supported or funded but driven by interesting imagination and curiosity. Recollected in this minireview is its establishing and developing processes, as well as its philosophy and accomplishments.

scholarly journals Recombinant Protein Vaccines, a Proven Approach Against Coronavirus Pandemics

2020 ◽  
Author(s):  
Jeroen Pollet ◽  
Wen-Hsiang Chen ◽  
Ulrich Strych
Keyword(s):  
Nucleic Acid ◽  
Recombinant Protein ◽  
Research And Development ◽  
Viral Vector ◽  
Public Information ◽  
Development Status ◽  
The World ◽  
Protein Vaccines ◽  
Initial Focus ◽  
Global Research

With the COVID-19 pandemic now ongoing for close to a year, people all over the world are still waiting for a vaccine to become available. The initial focus of accelerated global research and development efforts to bring a vaccine to market as soon as possible was on novel platform technologies that promised speed but had limited history in the clinic. In contrast, recombinant protein vaccines, with numerous examples in the clinic for many years, missed out on the early wave of investments from government and industry. Emerging data are now surfacing suggesting that recombinant protein vaccines indeed might offer an advantage or complement to the nucleic acid or viral vector vaccines that will likely reach the clinic faster. Here, we summarize the current public information on the nature and on the development status of recombinant subunit antigens and adjuvants targeting SARS-CoV-2 infections.

The chronicle of COVID-19: possible strategies to curb the pandemic

2020 ◽  
Vol 27 ◽  
Author(s):  
Rajesh Kumar ◽  
Seetha Harilal ◽  
Abdullah G. Al-Sehemi ◽  
Githa Elizabeth Mathew ◽  
Simone Carradori ◽  
...  
Keyword(s):  
Life Cycle ◽  
Research And Development ◽  
Vaccine Development ◽  
Therapeutic Strategies ◽  
Antiviral Drugs ◽  
Limited Data ◽  
Social Distancing ◽  
The World ◽  
Novel Virus ◽  
Day By Day

: COVID-19, an epidemic that emerged in Wuhan, has become a pandemic affecting worldwide and is in a rapidly evolving condition. Day by day, the confirmed cases and deaths are increasing many folds. SARS-CoV-2 is a novel virus; therefore, limited data are available to curb the disease. Epidemiological approaches, isolation, quarantine, social distancing, lockdown, and curfew are being employed to halt the spread of the disease. Individual and joint efforts all over the world are producing a wealth of data and information which are expected to produce therapeutic strategies against COVID-19. Current research focuses on the utilization of antiviral drugs, repurposing strategies, vaccine development as well as basic to advanced research about the organism and the infection. The review focuses on the life cycle, targets, and possible therapeutic strategies, which can lead to further research and development of COVID-19 therapy.

A Bibliometric Analysis of Global Research on Lophomonas sp. in Scopus (1933-2019)

2020 ◽  
Vol 20 ◽  
Author(s):  
Masoud Keighobadi ◽  
Maryam Nakhaei ◽  
Ali Sharifpour ◽  
Ali Akbar Khasseh ◽  
Sepideh Safanavaei ◽  
...  
Keyword(s):  
Bibliometric Analysis ◽  
International Collaboration ◽  
Research Articles ◽  
High Quality ◽  
The Real ◽  
The Us ◽  
The World ◽  
Scopus Database ◽  
Number Of Publications ◽  
Global Research

Background: This study was designed to analyze the global research on Lophomonas spp. using bibliometric techniques. Methods: A bibliometric research was carried out using the Scopus database. The analysis unit was the research articles conducted on Lophomonas spp. Results: Totally, 56 articles about Lophomonas spp. were indexed in the Scopus throughout 1933-2019 ( 87 years ) with the following information: (A) The first article was published in 1933; (B) 21 different countries contributed in studies related to Lophomonas spp.; (C) China ranked first with 16 publications about Lophomonas spp.; and (D) “Brugerolle, G” and “Beams, H.W.” from France and the US participated in 4 articles respectively, as the highest number of publications in the Lophomonas spp. network. Discussion: After 87 years, Lophomonas still remains unknown for many researchers and physicians around the world. Further studies with high quality and international collaboration are urgently needed to determine different epidemiological aspects and the real burden of the mysterious parasite worldwide.

scholarly journals Antibiotic Pipeline Coordinators

2018 ◽  
Vol 46 (S1) ◽  
pp. 25-31 ◽  
Author(s):  
Enrico Baraldi ◽  
Olof Lindahl ◽  
Miloje Savic ◽  
David Findlay ◽  
Christine Årdal
Keyword(s):  
Research And Development ◽  
World Health ◽  
Resistant Bacteria ◽  
Antibiotic Resistant ◽  
Priority List ◽  
Non Profit ◽  
Global Priority ◽  
The World ◽  
New Antibiotics ◽  
Health Organization

The World Health Organization (WHO) has published a global priority list of antibiotic-resistant bacteria to guide research and development (R&D) of new antibiotics. Every pathogen on this list requires R&D activity, but some are more attractive for private sector investments, as evidenced by the current antibacterial pipeline. A “pipeline coordinator” is a governmental/non-profit organization that closely tracks the antibacterial pipeline and actively supports R&D across all priority pathogens employing new financing tools.

Equipment for thermal process

2020 ◽  
pp. 10-23
Author(s):  
D.V. Novikov
Keyword(s):  
Thermal Treatment ◽  
Research And Development ◽  
Thermal Process ◽  
New Products ◽  
Minimal Cost ◽  
Multiple Use ◽  
Thermal Equipment ◽  
Practical Research ◽  
The World ◽  
Vacuum Furnaces

The demand for efficient and qualitative thermal treatment makes certain requirements to the thermal equipment. The thermal equipment, that ideally corresponds to the assigned task of modern production facilities, is vacuum furnaces. The modern production requirements are the boundary conditions for the equipment manufacturers, focusing them on the need for all in one equipment capable of efficient wide production maneuvering, to ensure the possibility of developing and producing new products at minimal cost. As a result of practical research and development, focusing on the world experience and the real need for operation, the Sistem Teknik's article presents vacuum thermal equipment for multiple use – All in one. The equipment is controlled automatically, all parameters are regulated by the process master controller in compliance with the programmed cycle.

BRICS Countries Possible Areas for Scientific Cooperation

2015 ◽  
pp. 14-23
Author(s):  
I. Dezhina
Keyword(s):  
Research And Development ◽  
New Technologies ◽  
Technological Development ◽  
High Tech ◽  
Preliminary Evaluation ◽  
Exploratory Research ◽  
Scientific Cooperation ◽  
Brics Countries ◽  
The World ◽  
A Share

The article evaluates science sectors and effectiveness of scientific research in the countries forming the BRICS group, as well as the current state of scientific and technological cooperation among the group members. The science sectors of the countries under consideration differ markedly, while facing similar problems relating to government regulations and external environments. The differences exist in total expenditures on research and development (as a share of GNP), in the scope of governmental funding (large in Russia and India, but small in China), and in the distribution of allocations among various areas and types of R&D activities. China appears to have the most well-adjusted science sector among the BRICS members. It includes not only strong universities but also high-tech companies that invest actively into research and development. The overall impact (inferred from citation indexes) of fundamental and exploratory research performed in BRICS countries remains low. BRICS's scientists prefer to collaborate with their colleagues from the world-leading countries rather than with their fellows from BRICS. Yet, in contrast to the world trend, in all BRICS countries, except Russia, a share of internationally co-authored publications is now decreasing. BRICS members have more similar interests and priorities in technological development, including infrastructural and large technological projects, than in science. Currently, bilateral cooperation in technology prevails, while the projects involving all members of the group still remain at the stage of preliminary evaluation and discussion. Russia cooperates most closely with China and India, including joint projects in such high-priority directions as new materials, photonics, biomedical, space and information technologies. For Russia, cooperation in technological development appears to be of most interest because it can lead not only to introduction of new technologies but also help to create large Russian innovative companies. Development of successful multilateral cooperation in science and technology among the BRICS members is the key for this group, originally formed for geopolitical reasons, to evolve into an effective economic union.

Sign in / Sign up

Export Citation Format

Share Document